Agenda
RedHill Biopharma Ltd.
NASDAQ: RDHL
Industry: Biopharmaceutical – Gastrointestinal and Infectious Diseases
Guy Goldberg, Chief Business Officer
RespireRx Pharmaceuticals Inc.
OTCQB: RSPI
Industry: Biopharmaceuticals - Psychiatric and Neurological Disorders
Jeff Margolis, Senior Vice President, Secretary, Treasurer, Chief Financial Officer & Member of the Board of Directors
Relief Therapeutics Holdings SA
OTCQB: RLFTF | SIX: RLF
Industry: Biopharmaceutical - Respiratory and Rare and Specialty Indications
Jack Weinstein, CFO & Treasurer
VolitionRx Limited
NYSE AMERICAN: VNRX
Industry: Epigenetics - Cancer Screening/Veterinary
Scott Powell, Head of Investor Relations & U.S. Chief Financial Officer
Mind Cure Health Inc.
OTCQX: MCURF | CSE: MCUR
Industry: Pharma - Psychedelics - Mental Health
Kelsey Ramsden, President & CEO
Alpha Cognition, Inc.
OTCQB: ACOGF | TSX-V: ACOG
Industry: Biopharmaceuticals - Alzheimer’s and ALS
Michael McFadden, CEO
Emmaus Life Sciences, Inc.
OTCQX: EMMA
Industry: Biopharmaceuticals - Rare and Orphan Diseases
Yutaka Niihara, CEO & Chairman of the Board
Jack Nathan Medical Corp.
OTCQB: JNHMF | TSX-V: JNH
Industry: Primary Care Medical Clinics
Glenn Copeland, CEO & CMO
David Berman, CFO
ReShape Lifesciences Inc.
NASDAQ: RSLS
Industry: Weight Loss and Metabolic Health
Bart Bandy, CEO & President
Tom Stankovich, CFO
Else Nutrition Holdings Inc.
OTCQX: BABYF | TSX-V: BABY
Industry: Plant-Based Nutrition
Hamutal Yitzhak, Co - Founder, CEO
Salarius Pharmaceuticals, Inc.
Nasdaq: SLRX
Industry: Biopharmaceutical – Cancer
David Arthur, CEO
Satellos Bioscience Inc.
Pink: MSCLF | TSX-V: MSCL
Industry: Biotechnology - regenerative medicine
Frank Gleeson, Founder & CEO
Rakovina Therapeutics Inc.
TSX-V: RKV
Industry: Biopharmaceuticals – Cancer
Jeffrey Bacha, Executive Chairman